Katherine Hsiao, EVP and Head of Health and Life Sciences at Palantir Technologies, is a senior business leader responsible for deploying Palantir’s secure enterprise software against challenges ranging from Cancer to COVID-19 vaccine research. Her expertise centers on the intersection of health, tech, policy, and cross-sector collaboration, most recently leveraged to propel the new era of data sharing in biomedical research in the US. Katherine also recently served on the WEF’s Global Future Council for Data Policy, a committee focused on shaping the future of technology governance. Prior to assuming her leadership role, Katherine spent 7 years growing revenue streams across Palantir’s enterprise clients and leading Palantir’s philanthropic initiatives. Katherine previously led Business Development and partnerships for the Clinton Global Initiative and has degrees in Philosophy and Biomedical Ethics from New York University.